Big problems loom over the pharmaceutical industry which influences so many people's lives. Giant corporations are beset by scandal and their pipelines of new treatments are running dry. Peter Day looks at the future of the industry through the eyes of two Swiss pharma companies, one very big and one of them tiny. Both are linked by their quest for a treatment for Alzheimers.